SEC Form 4 · accession 0001209191-16-110436
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen Merrigan
Director
Period of report
Mar 22, 2016
Accepted (ET)
Mar 24, 2016 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 22, 2016 | A | 35,906 | A | — | — | Common Stock | 35,906 | 35,906 | D |
| Restricted Stock UnitsF1,F3 | — | Mar 22, 2016 | A | 3,740 | A | — | — | Common Stock | 3,740 | 3,740 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
- F2The restricted stock units vest with respect to 1/3rd of the total shares on the first anniversary of the vesting commencement date of March 22, 2016, and with respect to 1/24th of the remaining shares subject to the grant monthly thereafter for 24 months. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- F3The restricted stock units vest with respect to 100% of the total shares subject to the grant on the date of the 2016 annual stockholder meeting. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.